Immediate Impact
4 standout
Citing Papers
Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies
2024 Standout
Biologics, theranostics, and personalized medicine in drug delivery systems
2024 Standout
Works of Brooke Diorio being referenced
Phase 3 MAGNITUDE study: First results of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) as first-line therapy in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with and without homologous recombination repair (HRR) gene alterations.
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Brooke Diorio | 86 | 76 | 22 | 23 | 5 | 94 | |
| V.S. Sakalo | 70 | 61 | 20 | 20 | 4 | 80 | |
| Bram Wieskopf | 93 | 63 | 19 | 47 | 3 | 164 | |
| Sandeep H. Mashru | 53 | 69 | 20 | 25 | 6 | 94 | |
| Judy Hess | 47 | 39 | 24 | 58 | 4 | 89 | |
| Penny Towne | 53 | 69 | 28 | 19 | 8 | 87 | |
| Christian Boch | 109 | 94 | 44 | 40 | 4 | 146 | |
| Ze-Fei Jiang | 34 | 79 | 22 | 27 | 6 | 111 | |
| Tea Zeppola | 51 | 88 | 49 | 34 | 6 | 126 | |
| Emanuela Pozzi | 47 | 37 | 25 | 21 | 5 | 89 | |
| Linnea Fulton | 63 | 55 | 17 | 20 | 6 | 79 |
All Works
Loading papers...